4.7 Article

Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases

期刊

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.02534-16

关键词

KPC; ceftazidime-avibactam; drug resistance mechanisms; site-directed mutagenesis

资金

  1. National Institutes of Health [UM1AI104681, R21AI288338, R21AI111037, K08AI114883]

向作者/读者索取更多资源

We identified four bla(KPC-3) mutations in ceftazidime-avibactam-resistant clinical Klebsiella pneumoniae isolates, corresponding to D179Y, T243M, D179Y/T243M, and EL165-166 KPC-3 variants. Using site-directed mutagenesis and transforming vectors into Escherichia coli, we conclusively demonstrated that mutant bla(KPC-3) encoded enzymes that functioned as extended-spectrum beta-lactamases; mutations directly conferred higher MICs of ceftazidime-avibactam and decreased the MICs of carbapenems and other beta-lactams. Impact was strongest for the D179Y mutant, highlighting the importance of the KPC Omega-loop.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据